Skip to main content
Log in

Cardiovascular disease as a late complication of end-stage renal disease in children

  • Review
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

As in older adults, cardiovascular disease is the most important cause of death in adolescents and young adult patients with end-stage renal disease (ESRD) since childhood. This concerns patients on dialysis as well as transplant patients, despite the fact that a long duration of dialysis during childhood is an extra mortality risk factor. Left ventricular hypertrophy (LVH), aortic valve calcification, and increased arterial stiffness, but not increased arterial intima media thickening, are the most frequently observed alterations in young adult survivors with childhood ESRD. In transplanted patients a concentric LVH as a result of chronic hypertension is mostly observed; in dialysis patients a more asymmetric septal LVH is found as a result of chronic volume overload. These results suggest that in children and young adults with ESRD chronic pressure and volume overload, a high calcium-phosphate product, and chronic inflammation, but not dyslipidemia, play a role in the development of cardiovascular disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Foley RN, Parfrey PS (1998) Cardiovascular disease and mortality in ESRD. J Nephrol 11:239–245

    CAS  PubMed  Google Scholar 

  2. London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, Metivier F, Adda H, Safar ME (2001) Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol 12:2759–2767

    CAS  PubMed  Google Scholar 

  3. Huting J (1993) Predictive value of mitral and aortic valve sclerosis for survival in end-stage renal disease on continuous ambulatory peritoneal dialysis. Nephron 64:63–68

    CAS  PubMed  Google Scholar 

  4. Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME, London GM (1998) Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 32:570–574

    CAS  PubMed  Google Scholar 

  5. Groothoff JW, Gruppen MP, Offringa M, Hutten J, Lilien MR, Van De Kar NJ, Wolff ED, Davin JC, Heymans HAS (2002) Mortality and causes of death of end-stage renal disease in children: a Dutch cohort study. Kidney Int 61:621–629

    Article  PubMed  Google Scholar 

  6. Gruppen MP, Groothoff JW, Prins M, Wouw P van der, Offringa M, Bos WJ, Davin JC, Heymans HAS (2003) Cardiac disease in young adult patients with end-stage renal disease since childhood: a Dutch cohort study. Kidney Int 63:1058–1065

    Article  PubMed  Google Scholar 

  7. Groothoff JW, Gruppen MP, Offringa M, Groot E de, Stok W, Bos WJ, Davin JC, Lilien MR, Van de Kar NC, Wolff ED, Heymans HAS (2002) Increased arterial stiffness in young adults with end-stage renal disease since childhood. J Am Soc Nephrol 13:2953–2961

    PubMed  Google Scholar 

  8. Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F (2002) Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106:100–105

    Article  PubMed  Google Scholar 

  9. London GM, Marchais SJ, Guerin AP, Metivier F, Pannier B (1993) Cardiac hypertrophy and arterial alterations in end-stage renal disease: hemodynamic factors. Kidney Int [Suppl 41]:S42–S49

  10. Hotta T, Happonen JM, Ronnholm K, Fyhrquist F, Holmberg C (2001) Hypertension, cardiac state, and the role of volume overload during peritoneal dialysis. Pediatr Nephrol 16:324–331

    Article  Google Scholar 

  11. Mitsnefes MM, Kimball TR, Witt SA, Glascock BJ, Khoury PR, Daniels SR (2003). Left ventricular mass and systolic performance in pediatric patients with chronic renal failure. Circulation 107:864–868

    Article  PubMed  Google Scholar 

  12. Mitsnefes MM, Schwartz SM, Daniels SR, Kiball TR, Khoury P, Dtrife CF (2001) Changes in left ventricular mass index in children and adolescents after renal transplantation. Pediatr Transplant 5:279–284

    CAS  PubMed  Google Scholar 

  13. London GM, Pannier B, Marchais SJ, Guerin AP (2000) Calcification of the aortic valve in the dialyzed patient. J Am Soc Nephrol 11:778–783

    CAS  PubMed  Google Scholar 

  14. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC (1996) Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 27:394–401

    CAS  PubMed  Google Scholar 

  15. Shurmur SW, D’Elia JA, Gleason RE, Nesto RW, DeSilva RA, Weinrauch LA (1990) Cardiac conduction defects associated with aortic and mitral valve calcification in dialysis patients. Ren Fail 12:103–107

    CAS  PubMed  Google Scholar 

  16. Fernandez-Reyes MJ, Auxiliadora Bajo M, Robles P, Selgas R, Oliver J, Del Peso G, Garcia G, Jimenez C, Garcia-Gallego F (1995) Mitral annular calcification in CAPD patients with a low degree of hyperparathyroidism. An analysis of other possible risk factors. Nephrol Dial Transplant 10:2090–2095

    CAS  PubMed  Google Scholar 

  17. Issad B, Mouquet C, Bitker MO, Allouache M, Baumelou A, Rottembourg J, Jacobs C (1994) Is overhydration in CAPD patients a contraindication to renal transplantation? Adv Perit Dial 10:68–72

    CAS  PubMed  Google Scholar 

  18. Merkus MP, Jager KJ, Dekker FW, Haan RJ de, Boeschoten EW, Krediet RT (1999) Cardiovascular and non-cardiovascular survival. The NECOSAD Study Group, in Patients Outcomes in Dialysis Care. Thesis University of Amsterdam

  19. Anwar N, Hutchinson AJ, Gokal R (1993) Comparison of renal osteodystrophy in patients undergoing continuous ambulatory peritoneal dialysis and hemodialysis. Perit Dial Int 13 [Suppl]:S451–S453

  20. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB (2000) Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478–1483

    Article  CAS  PubMed  Google Scholar 

  21. Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, Bohm R, Metzger T, Wanner C, Jahnen-Dechent W, Floege J (2003) Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 361:827–833

    Article  CAS  PubMed  Google Scholar 

  22. Lebreton JP, Joisel F, Raoult JP, Lannuzel B, Rogez JP, Humbert G (1979) Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant. J Clin Invest 64:1118–1129

    CAS  PubMed  Google Scholar 

  23. Schinke T, Amendt C, Trindl A, Poschke O, Muller-Esterl W, Jahnen-Dechent W (1996) The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis. J Biol Chem 271:20789–20796

    Article  CAS  PubMed  Google Scholar 

  24. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM (2001) Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 103:987–992

    CAS  PubMed  Google Scholar 

  25. Barenbrock M, Kosch M, Joster E (2002): Reduced arterial distensibility is a predictor of cardiovascular disease in patients after renal transplantation. J Hypertens 20:79–84

    Article  CAS  PubMed  Google Scholar 

  26. Girerd X, Laurent S, Pannier B, Asmar R, Safar M (1991) Arterial distensibility and left ventricular hypertrophy in patients with sustained essential hypertension. Am Heart J 122:1210–1214

    Article  CAS  PubMed  Google Scholar 

  27. Senzaki H, Akagi M, Hishi T, Ishizawa A, Yanagisawa M, Masutani S, Kobayashi T, Awa S (2002) Age associated changes in arterial elastic properties in children. Eur J Pediatr 161:547–551

    Article  PubMed  Google Scholar 

  28. Eifinger F, Wahn F, Querfeld U, Pollok M, Gevargez A, Kriener P, Gronemeyer D (2000) Coronary artery calcifications in children and young adults treated with renal replacement therapy. Nephrol Dial Transplant 15:1892–1894

    Article  CAS  PubMed  Google Scholar 

  29. Lilien MR, Stroes ES, Op’t Roodt J, Jongh S de, Schroder CH, Koomans HA (2003) Vascular function in children after renal transplantation. Am J Kidney Dis 41:684–691

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jaap W. Groothoff.

Additional information

This work was presented in part at the IPNA Seventh Symposium on Growth and Development in Children with Chronic Kidney Disease: The Molecular Basis of Skeletal Growth, 1–3 April 2004, Heidelberg, Germany

Rights and permissions

Reprints and permissions

About this article

Cite this article

Groothoff, J.W., Lilien, M.R., van de Kar, N.C.A.J. et al. Cardiovascular disease as a late complication of end-stage renal disease in children. Pediatr Nephrol 20, 374–379 (2005). https://doi.org/10.1007/s00467-004-1624-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-004-1624-8

Keywords

Navigation